Prospects for vaccination against the ticks of pets and the potential impact on pathogen transmission

Veterinary Parasitology

Volumn 208, Issue 1-2, 2015, Pages 26-29

  de La Fuente, José ^a,b   Villar, Margarita ^a   Contreras, Marinela ^a   Moreno Cid, Juan A ^a   Merino, Octavio ^a   Pérez de la Lastra, José M ^a   de la Fuente, Gabriela ^a   Galindo, Ruth C ^a,b  

^a INSTITUTO DE INVESTIGACIÓN EN RECURSOS CINEGÉTICOS IREC CSIC UCLM JCCM   (Spain)

^b OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Dog; Ectoparasite; Infection; Tick; Vaccine

Indexed keywords

AKIRIN; ANTIGEN; BM 86; BM86; PROTECTIVE ANTIGEN; PROTEIN; SUBOLESIN; TICK VACCINE; UNCLASSIFIED DRUG; VACCINE; ARTHROPOD PROTEIN;

ANIMAL HEALTH; ARTICLE; CAT; DISEASE ERADICATION; DISEASE TRANSMISSION; DOG; DRUG DESIGN; ECTOPARASITE; NONHUMAN; PARASITE VECTOR; PET ANIMAL; TICK; TICK BORNE DISEASE; VACCINATION; VECTOR CONTROL; ANIMAL; HUMAN; IMMUNOLOGY; TICK INFESTATIONS; TICK-BORNE DISEASES;

ANIMALIA; ARTHROPODA; CANIS FAMILIARIS; IXODIDA;

ANIMALS; ARTHROPOD PROTEINS; HUMANS; TICK INFESTATIONS; TICK-BORNE DISEASES; TICKS; VACCINATION;

EID: 84923347300     PISSN: 03044017     EISSN: 18732550     Source Type: Journal    
DOI: 10.1016/j.vetpar.2014.12.015     Document Type: Article

References (41)

1. Allen J.R., Humphreys S.J. Immunisation of guinea pigs and cattle against ticks. Nature 1979, 280:491-493.
2. Anatriello E., Ribeiro J.M., de Miranda-Santos I.K., Brandão L.G., Anderson J.M., Valenzuela J.G., Maruyama S.R., Silva J.S., Ferreira B.R. An insight into the sialotranscriptome of the brown dog tick Rhipicephalus sanguineus. BMC Genomics 2010, 11:450.
3. Bensaci M., Bhattacharya D., Clark R., Hu L.T. Oral vaccination with vaccinia virus expressing the tick antigen subolesin inhibits tick feeding and transmission of Borrelia burgdorferi. Vaccine 2012, 30:6040-6046.
4. Beugnet F., Marié J.L. Emerging arthropod-borne diseases of companion animals in Europe. Vet. Parasitol. 2009, 163:298-305.
5. Bratu S., Lutwick L.I. Active immunisation against human tick-borne diseases. Expert Opin. Biol. Ther. 2002, 2:187-195.
6. Canales M., Naranjo V., Almazán C., Molina R., Tsuruta S.A., Szabó M.P., Manzano-Roman R., Pérez de la Lastra J.M., Kocan K.M., Jiménez M.I., Lucientes J., Villar M., de la Fuente J. Conservation and immunogenicity of the mosquito ortholog of the tick-protective antigen, subolesin. Parasitol. Res. 2009, 105:97-111.
7. Coller B.A., Clements D.E., Martyak T., Yelmene M., Thorne M., Parks D.E. Advances in flavivirus vaccine development. IDrugs 2012, 13:880-884.
8. Day M.J. The immunopathology of canine vector-borne diseases. Parasites Vectors 2011, 4:48.
9. de la Fuente J. Vaccines for vector control: exciting possibilities for the future. Vet. J. 2012, 194:139-140.
10. de la Fuente J., Kocan K.M. Advances in the identification and characterization of protective antigens for development of recombinant vaccines against tick infestations. Expert Rev. Vaccines 2003, 2:583-593.
11. de la Fuente J., Kocan K.M. Strategies for development of vaccines for control of ixodid tick species. Parasite Immunol. 2006, 28:275-283.
12. de la Fuente J., Estrada-Peña A. Ticks and tick-borne pathogens on the rise. Ticks Tick-Borne Dis. 2012, 3:115-116.
13. de la Fuente J., Merino O. Vaccinomics, the new road to tick vaccines. Vaccine 2013, 31:5923-5929.
14. de la Fuente J., Almazán C., Blouin E.F., Naranjo V., Kocan K.M. Reduction of tick infections with Anaplasma marginale and A. phagocytophilum by targeting the tick protective antigen subolesin. Parasitol. Res. 2006, 100:85-91.
15. de la Fuente J., Almazán C., Blas-Machado U., Naranjo V., Mangold A.J., Blouin E.F., Gortazar C., Kocan K.M. The tick protective antigen, 4D8, is a conserved protein involved in modulation of tick blood digestion and reproduction. Vaccine 2006, 24:4082-4095.
16. de la Fuente J., Almazán C., Naranjo V., Blouin E.F., Meyer J.M., Kocan K.M. Autocidal control of ticks by silencing of a single gene by RNA interference. Biochem. Biophys. Res. Commun. 2006, 344:332-338.
17. de la Fuente J., Almazán C., Naranjo V., Blouin E.F., Kocan K.M. Synergistic effect of silencing the expression of tick protective antigens 4D8 and Rs86 in Rhipicephalus sanguineus by RNA interference. Parasitol. Res. 2006, 99:108-113.
18. de la Fuente J., Almazán C., Canales M., Pérez de la Lastra J.M., Kocan K.M., Willadsen P. A ten-year review of commercial vaccine performance for control of tick infestations on cattle. Anim. Health Res. Rev. 2007, 8:23-28.
19. de la Fuente J., Estrada-Peña A., Venzal J.M., Kocan K.M., Sonenshine D.E. Overview: ticks as vectors of pathogens that cause disease in humans and animals. Front. Biosci. 2008, 13:6938-6946.
20. de la Fuente J., Moreno-Cid J.A., Canales M., Villar M., Pérez de la Lastra J.M., Kocan K.M., Galindo R.C., Almazán C., Blouin E.F. Targeting arthropod subolesin/akirin for the development of a universal vaccine for control of vector infestations and pathogen transmission. Vet. Parasitol. 2011, 181:17-22.
21. de la Fuente J., Moreno-Cid J.A., Villar M., Galindo R.C., Almazán C., Kocan K.M., Merino O., Pérez de la Lastra J.M., Estrada-Peña A., Blouin E.F. Subolesin/akirin vaccines for the control of arthropod vectors and vector-borne pathogens. Transbound Emerg. Dis. 2013, 60(Suppl. 2):172-178.
22. Glickman L.T., Moore G.E., Glickman N.W., Caldanaro R.J., Aucoin D., Lewis H.B. Purdue University-Banfield National Companion Animal Surveillance Program for emerging and zoonotic diseases. Vector Borne Zoonotic Dis. 2006, 6:14-23.
23. Hajdušek O., Šíma R., Ayllón N., Jalovecká M., Perner J., de la Fuente J., Kopáček P. Interaction of the tick immune system with transmitted pathogens. Front. Cell. Infect. Microbiol. 2013, 3:26.
24. Hall-Mendelin S., Craig S.B., Hall R.A., O'Donoghue P., Atwell R.B., Tulsiani S.M., Graham G.C. Tick paralysis in Australia caused by Ixodes holocyclus Neumann. Ann. Trop. Med. Parasitol. 2011, 105:95-106.
25. Karunamoorthi K. Vector control: a cornerstone in the malaria elimination campaign. Clin. Microbiol. Infect. 2011, 17:1608-1616.
26. Masina S., Broady K.W. Tick paralysis: development of a vaccine. Int. J. Parasitol. 1999, 29:535-541.
27. Merino O., Alberdi P., Pérez de la Lastra J.M., de la Fuente J. Tick vaccines and the control of tick-borne pathogens. Front. Cell. Infect. Microbiol. 2013, 3:30.
28. Moreno-Cid J.A., Jiménez M., Cornelie S., Molina R., Alarcón P., Lacroix M.-N., Pinal R., Delacour S., Lucientes J., Canales M., Pérez de la Lastra J.M., Villar M., de la Fuente J. Characterization of Aedes albopictus akirin for the control of mosquito and sand fly infestations. Vaccine 2011, 29:77-82.
29. Moreno-Cid J.A., Pérez de la Lastra J.M., Villar M., Jiménez M., Pinal R., Estrada-Peña A., Alarcón P., Delacour S., Oropeza V., Ruiz I., Molina R., Lucientes J., Prudencio C.R., Galindo R.C., Almazán C., Nijhof A.M., Mangold A.J., Gortázar C., de la Fuente J. Control of multiple arthropod vector infestations with subolesin/akirin vaccines. Vaccine 2013, 31:1187-1196.
30. Merino O., Almazán C., Canales M., Villar M., Moreno-Cid J.A., Estrada-Peña A., Kocan K.M., de la Fuente J. Control of Rhipicephalus (Boophilus) microplus infestations by the combination of subolesin vaccination and tick autocidal control after subolesin gene knockdown in ticks fed on cattle. Vaccine 2011, 29:2248-2254.
31. Merino O., Almazán C., Canales M., Villar M., Moreno-Cid J.A., Galindo R.C., de la Fuente J. Targeting the tick protective antigen subolesin reduces vector infestations and pathogen infection by Anaplasma marginale and Babesia bigemina. Vaccine 2011, 29:8575-8579.
32. Otranto D., Dantas-Torres F., Tarallo V.D., Ramos R.A., Stanneck D., Baneth G., de Caprariis D. Apparent tick paralysis by Rhipicephalus sanguineus (Acari: Ixodidae) in dogs. Vet Parasitol. 2012, 188:325-329.
33. Perez-Perez D., Bechara G.H., Machado R.Z., Andrade G.M., Del Vecchio R.E., Pedroso M.S., Hernández M.V., Farnós O. Efficacy of the Bm86 antigen against immature instars and adults of the dog tick Rhipicephalus sanguineus (Latreille, 1806) (Acari: Ixodidae). Vet. Parasitol. 2010, 167:321-326.
34. Rand K.N., Moore T., Sriskantha A., Spring K., Tellam R., Willadsen P., Cobon G. Cloning and expression of a protective antigen from the cattle tick Boophilus microplus. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:9657-9661.
35. Rodríguez-Mallon A., Fernández E., Encinosa P.E., Bello Y., Méndez-Pérez L., Ruiz L.C., Pérez D., González M., Garay H., Reyes O., Méndez L., Estrada M.P. A novel tick antigen shows high vaccine efficacy against the dog tick, Rhipicephalus sanguineus. Vaccine 2012, 30:1782-1789.
36. Sperança M.A., Capurro M.L. Perspectives in the control of infectious diseases by transgenic mosquitoes in the post-genomic era-a review. Mem. Inst. Oswaldo Cruz 2007, 102:425-433.
37. Szabó M.P., Bechara G.H. Immunisation of dogs and guinea pigs against Rhipicephalus sanguineus ticks using gut extract. Vet. Parasitol. 1997, 68:283-294.
38. Trimnell A.R., Davies G.M., Lissina O., Hails R.S., Nuttall P.A. A cross-reactive tick cement antigen is a candidate broad-spectrum tick vaccine. Vaccine 2005, 23:4329-4341.
39. Vancová I., Hajnická V., Slovák M., Kocáková P., Paesen G.C., Nuttall P.A. Evasin-3-like anti-chemokine activity in salivary gland extracts of ixodid ticks during blood-feeding: a new target for tick control. Parasite Immunol. 2010, 32:460-463.
40. Villar M., Torina A., Nuñez Y., Zivkovic Z., Marina A., Alongi A., Scimeca S., La Barbera G., Caracappa S., Vázquez J., de la Fuente J. Application of highly sensitive saturation labeling to the analysis of differential protein expression in infected ticks from limited samples. Proteome Sci. 2010, 8:43.
41. Willadsen P. Anti-tick vaccines. Parasitology 2004, 129:S367-S874.